- $1.84bn
- $1.82bn
- $105.97m
Zymeworks Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Zymeworks Announces Appointment Of Oleg Nodelman To Board Of Directors
U.S. STOCKS ON THE MOVE-Teradyne, Keysight Technologies, Ametek
Zymeworks jumps after JPM upgrades stock to 'overweight'
U.S. RESEARCH ROUNDUP-Amazon, Broadcom, Exxon Mobil
Press Digest: Canada - Nov 22
Brief: Zymeworks Doses First Patient In Phase 1 Trial Of ZW191 For Folate Receptor-⍺ Positive Advanced Tumors
Zymeworks Inc reports results for the quarter ended in January 1 - Earnings Summary
Brief: Zymeworks Q3 Pretax Profit USD -29.624 Million
Zymeworks Inc expected to post a loss of 40 cents a share - Earnings Preview
Zymeworks Inc reports results for the quarter ended in June - Earnings Summary
Brief: Zymeworks Announces Share Repurchase Program Of Up To $60 Million Of Its Common Stock
Brief: Zymeworks Q2 Pretax Profit USD -37.618 Million
Zymeworks Inc expected to post a loss of 32 cents a share - Earnings Preview
Brief: Zymeworks Appoints Leone Patterson As Chief Business And Financial Officer
Brief: Zymeworks Gets FDA Clearance Of Investigational New Drug Application For ZW191
U.S. STOCKS ON THE MOVE-Broadcom, Xponential Fitness, Northfield Bancorp
U.S. STOCKS ON THE MOVE-Broadcom, Xponential Fitness, Northfield Bancorp
U.S. STOCKS ON THE MOVE-Autodesk, Aaron's Company